查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1610246

药用甘油市场：按应用、来源分类 - 2025-2030 年全球预测

Pharmaceutical Glycerine Market by Utility (Care Products, Excipient), Source (Animal, Plant) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药用甘油市场价值为3747万美元，预计2024年将达3940万美元，复合年增长率为5.94%，预计2030年将达5613万美元。

药用甘油是一种多功能多元醇化合物，由于其无毒、吸湿和溶剂特性，在各种应用中发挥至关重要的作用。它主要用于药品、化妆品和个人保健产品中作为保湿剂、防腐剂和甜味剂。它的需求源自于其增强产品稳定性、质地和保质期的能力。最终用途包括从药物（作为活性成分的载体）到消费品（用于乳霜、乳液和胶囊）。市场成长受到消费者对健康和保健产品意识不断提高以及製药和化妆品行业需求不断增长的影响。生物技术应用的扩展，特别是药物传递系统的应用，意味着新商机的到来。这些趋势使公司能够探索甘油配方的创新，以提高生物有效性和功能。在永续性的推动下，对生物基甘油的研究不断增长，代表了绿色化学和环保产品潜在应用的另一个有前景的途径。然而，市场成长受到原材料价格波动以及有关产品安全和功效的严格监管要求等因素的限制。供应链中断是另一个挑战。公司可以透过投资多元化采购并遵守国际标准以确保产品一致性来缓解这些限制。在创新方面，甘油衍生物的增强、生物技术和精製製程的新应用等领域提供了差异化和竞争优势的机会。与研究机构合作可以促进这些领域的突破。儘管市场呈现稳定成长的特点，但竞争日益加剧，需要不断创新来维持市场地位。为了有效挖掘市场潜力，企业需要加强研发力度，并对不断变化的消费者偏好和监管环境做出快速反应。

主要市场统计
基准年[2023] 3747万美元
预计年份 [2024] 3940万美元
预测年份 [2030] 5613万美元
复合年增长率（%） 5.94%

市场动态：揭示快速发展的药用甘油市场的关键市场洞察

供需的动态交互作用正在改变药用甘油市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加在药物製剂中作为赋形剂的使用
    • 增加天然成分的使用
    • 增加在眼压疾病治疗的应用
  • 市场限制因素
    • 药用甘油的副作用
  • 市场机会
    • 活性化药用甘油的研发活动
    • 改善供应链和分销网络
  • 市场挑战
    • 低成本替代品的可用性

波特五力：驾驭药用甘油市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药用甘油市场的外部影响

外部宏观环境因素在塑造药用甘油市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解药用甘油市场的竞争状况

药用甘油市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵医药甘油市场供应商的绩效评估

FPNV 定位矩阵是评估药用甘油市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与推荐药物绘製甘油市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对药用甘油市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加在药物中作为赋形剂的使用
      • 增加天然成分的使用
      • 在眼压疾病治疗的应用不断增加
    • 抑制因素
      • 药用甘油的负面影响
    • 机会
      • 增加研发活动以开发药用甘油
      • 改善供应链和分销网络
    • 任务
      • 低成本替代品的可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药用甘油市场公共事业

  • 护理产品
  • 赋形剂

第七章药用甘油市场：依来源分类

  • 动物
  • 植物

第八章北美和南美药用甘油市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太药用甘油市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲药用甘油市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Archer Daniels Midland Company
  • Emery Oleochemicals Group
  • Fisher Scientific Co. LLC
  • GJ Chemical
  • Godrej Group
  • Merck KGaA
  • Munzer Bioindustrie GmbH
  • Oleon NV
  • Pon Pure Chemicals Group
  • Procter and Gamble Company
  • Reagents
  • Renewable Energy Group Inc.
  • Sulzer Ltd
  • The Chemical Company
  • Viterra Magdeburg GmbH
Product Code: MRR-742BD5183818

The Pharmaceutical Glycerine Market was valued at USD 37.47 million in 2023, expected to reach USD 39.40 million in 2024, and is projected to grow at a CAGR of 5.94%, to USD 56.13 million by 2030.

Pharmaceutical glycerine, a versatile polyol compound, plays a pivotal role in various applications due to its non-toxic, hygroscopic, and solvent properties. It is primarily used in drug formulations, cosmetics, and personal care products as a humectant, preservative, and sweetener. Its necessity stems from its ability to enhance the stability, texture, and shelf life of products. The end-use scope spans pharmaceuticals, where it acts as a carrier for active ingredients, to consumer goods where it is employed in creams, lotions, and capsules. Market growth is influenced by increasing demand from the pharmaceutical and cosmetics sectors, alongside rising consumer awareness concerning health and wellness products. The expansion in biotechnological applications, particularly in drug delivery systems, signifies an emerging opportunity. Embracing these trends, companies can explore innovations in glycerine formulations to improve bioavailability and functionality. Growing research into bio-based glycerine, driven by sustainability trends, represents another promising avenue, with potential applications in green chemistry and eco-friendly products. However, market growth is constrained by factors such as fluctuating raw material prices and stringent regulatory requirements regarding product safety and efficacy. Supply chain disruptions pose additional challenges. Companies can mitigate these limitations by investing in diversified sourcing and complying with international standards to ensure product consistency. Regarding innovation, areas such as enhanced glycerine derivatives, novel applications in biotechnology, and bio-refinery processes present opportunities for differentiation and competitive advantage. Collaborations with research institutions could facilitate breakthroughs in these areas. The market exhibits traits of steady growth, with increasing competition and a need for continuous innovation to maintain market position. Companies are urged to bolster research and development efforts and adapt swiftly to evolving consumer preferences and regulatory landscapes to harness market potential effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 37.47 million
Estimated Year [2024] USD 39.40 million
Forecast Year [2030] USD 56.13 million
CAGR (%) 5.94%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing usage as excipients in pharmaceutical preparations
    • Rising adoption of natural ingredients
    • Increasing application in the treatment of eye pressure conditions
  • Market Restraints
    • Adverse effects of pharmaceutical glycerine
  • Market Opportunities
    • Rising R&D activities to develop pharmaceutical glycerine
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Availability of low cost substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Glycerine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Glycerine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Glycerine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Glycerine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Glycerine Market

A detailed market share analysis in the Pharmaceutical Glycerine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Glycerine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Glycerine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Glycerine Market

A strategic analysis of the Pharmaceutical Glycerine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glycerine Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, Emery Oleochemicals Group, Fisher Scientific Co. L.L.C., GJ Chemical, Godrej Group, Merck KGaA, Munzer Bioindustrie GmbH, Oleon NV, Pon Pure Chemicals Group, Procter and Gamble Company, Reagents, Renewable Energy Group Inc., Sulzer Ltd, The Chemical Company, and Viterra Magdeburg GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glycerine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Utility, market is studied across Care Products and Excipient.
  • Based on Source, market is studied across Animal and Plant.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing usage as excipients in pharmaceutical preparations
      • 5.1.1.2. Rising adoption of natural ingredients
      • 5.1.1.3. Increasing application in the treatment of eye pressure conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of pharmaceutical glycerine
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities to develop pharmaceutical glycerine
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of low cost substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Glycerine Market, by Utility

  • 6.1. Introduction
  • 6.2. Care Products
  • 6.3. Excipient

7. Pharmaceutical Glycerine Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Plant

8. Americas Pharmaceutical Glycerine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Glycerine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Glycerine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Archer Daniels Midland Company
  • 2. Emery Oleochemicals Group
  • 3. Fisher Scientific Co. L.L.C.
  • 4. GJ Chemical
  • 5. Godrej Group
  • 6. Merck KGaA
  • 7. Munzer Bioindustrie GmbH
  • 8. Oleon NV
  • 9. Pon Pure Chemicals Group
  • 10. Procter and Gamble Company
  • 11. Reagents
  • 12. Renewable Energy Group Inc.
  • 13. Sulzer Ltd
  • 14. The Chemical Company
  • 15. Viterra Magdeburg GmbH

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GLYCERINE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GLYCERINE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY EXCIPIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 99. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023